Group One Trading
TARA icon

Group One Trading’s Protara Therapeutics TARA Stock Holding History

Group One Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.8K Sell
4,000
-2,500
-38% -$14.8K ﹤0.01% 5943
2025
Q4 		$34.6K Sell
6,500
-1,000
-13% -$5.56K ﹤0.01% 5897
2025
Q3 		$32.6K Buy
7,500
+7,000
+1,400% +$22.7K ﹤0.01% 6300
2025
Q2 		$1.51K Buy
+500
New +$1.73K ﹤0.01% 7484
2025
Q1 		– Sell
-34,100
Closed -$180K – 8358
2024
Q4 		$180K Buy
+34,100
New +$110K ﹤0.01% 4021
2024
Q3 		– Sell
-1,900
Closed -$3.95K – 7352
2024
Q2 		$3.95K Buy
+1,900
New +$5.55K ﹤0.01% 6047
2022
Q2 		– Sell
-1,200
Closed -$6K – 8509
2022
Q1 		$6K Sell
1,200
-300
-20% -$1.58K ﹤0.01% 7402
2021
Q4 		$10K Buy
1,500
+1,100
+275% +$7.58K ﹤0.01% 7358
2021
Q3 		$3K Buy
+400
New +$3.12K ﹤0.01% 7889

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Group One Trading's TARA Position: Q1 2026 in Review

Group One Trading reduced its Protara Therapeutics (TARA) stake by 93% in Q1 2026, selling an estimated $101K and leaving 1,297 shares worth $6.76K. The position accounts for ﹤0.01% of the portfolio, ranked #6571.

Group One Trading first reported a position in TARA in Q2 2024 and has held it in 5 quarters since. The position peaked at $98.1K in Q4 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Group One Trading held 1,297 shares of Protara Therapeutics worth $6.76K as of Q1 2026.
  • Group One Trading sold 17,103 Protara Therapeutics shares in Q1 2026, an estimated $101K.
  • Protara Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6571 holding.
  • Group One Trading first reported a position in Protara Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Group One Trading's Protara Therapeutics position peaked at $98.1K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.